Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 17OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Recurrence 1Lymphoma, B-Cell 1Leukemia, B-Cell 1

Interventions

Nivolumab 2fludarabine 1eltrombopag 1avelumab 1Immunotherapy, Adoptive 1Cyclophosphamide 1CTL019 chimeric antigen receptor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Lymphoma, B-Cell × Immunotherapy, Adoptive × Clear all
NCT03881774 2019-03-21

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Henan Cancer Hospital

Phase 1 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡